| 000 | 01768 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513230615.0 | ||
| 264 | 0 | _c20010607 | |
| 008 | 200106s 0 0 eng d | ||
| 022 | _a0015-0282 | ||
| 024 | 7 |
_a10.1016/s0015-0282(00)01632-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLudwig, M | |
| 245 | 0 | 0 |
_aHealth of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix. _h[electronic resource] |
| 260 |
_bFertility and sterility _cJan 2001 |
||
| 300 |
_a18-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aCongenital Abnormalities _xepidemiology |
| 650 | 0 | 4 | _aEmbryo Transfer |
| 650 | 0 | 4 |
_aEurope _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFertility Agents, Female _xadverse effects |
| 650 | 0 | 4 | _aFertilization in Vitro |
| 650 | 0 | 4 |
_aFetal Death _xepidemiology |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGermany _xepidemiology |
| 650 | 0 | 4 |
_aGonadotropin-Releasing Hormone _xadverse effects |
| 650 | 0 | 4 | _aHealth |
| 650 | 0 | 4 |
_aHormone Antagonists _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aOvary _xdrug effects |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy Complications _xepidemiology |
| 650 | 0 | 4 | _aTwins |
| 700 | 1 | _aRiethmüller-Winzen, H | |
| 700 | 1 | _aFelberbaum, R E | |
| 700 | 1 | _aOlivennes, F | |
| 700 | 1 | _aAlbano, C | |
| 700 | 1 | _aDevroey, P | |
| 700 | 1 | _aDiedrich, K | |
| 773 | 0 |
_tFertility and sterility _gvol. 75 _gno. 1 _gp. 18-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0015-0282(00)01632-0 _zAvailable from publisher's website |
| 999 |
_c11103112 _d11103112 |
||